Therapeutic effect enhancement

"Therapeutic effect enhancement" refers broadly to interventions or modifications that increase the efficacy of established treatments. Strategies documented under this term include the use of advanced drug delivery systems (such as nanoparticles, liposomes, and exosomes) to improve drug bioavailability and targeting[1][2][3][4], combination therapy with synergistic agents[5], and pharmaceutical formulation adjustments. However, this is a *process, technique, or intended pharmacologic outcome*, not the name of a molecule, receptor, enzyme, or pharmacologic target. Scientific literature and patents use "therapeutic effect enhancement" to describe a *goal* or *result* in drug development, but it does not refer to a defined or canonical biomolecular entity. Therefore, it should not be classified as a therapeutic target for structured therapeutic databases. *If you need structured information on a specific molecule, target, or therapeutic entity reported in the context of “therapeutic effect enhancement”—for example, a receptor (e.g., “PD-1 receptor”), or an enzyme (e.g., “Carbonic anhydrase”)—please specify the molecular entity, as entries for “therapeutic effect enhancement” are not directly mappable to such targets*[1][2][3][4][5][6].

Other names

Therapeutic efficacy improvementSynergistic drug effectPotentiation of pharmacologic action